These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29614970)

  • 21. Clinical impact of regional citrate anticoagulation in continuous renal replacement therapy in critically ill patients.
    Huguet M; Rodas L; Blasco M; Quintana LF; Mercadal J; Ortiz-Pérez JT; Rovira I; Poch E
    Int J Artif Organs; 2017 Nov; 40(12):676-682. PubMed ID: 28862718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study.
    Di Mario F; Regolisti G; Di Maria A; Parmigiani A; Benigno GD; Picetti E; Barbagallo M; Greco P; Maccari C; Fiaccadori E
    J Crit Care; 2021 Jun; 63():22-25. PubMed ID: 33611151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G; Demirbuga A; Annayev A; Citak A
    Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
    Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC
    Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional citrate anticoagulation for continuous renal replacement therapy.
    Kindgen-Milles D; Brandenburger T; Dimski T
    Curr Opin Crit Care; 2018 Dec; 24(6):450-454. PubMed ID: 30247214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality indicators in prolonged hemodialysis with regional citrate anticoagulation with the genius system: retrospective cohort of critical patients with acute kidney injury.
    Vieira JAM; Reinheimer IC; Dos Santos AC; Halperin FK; Susin LA; Staub LP; Ribeiro RJE; da Silveira JB; Fontoura LF; de Souza DC; Nunes KP; de Souza VC; da Silva Selistre L; Poli-de-Figueiredo CE
    BMC Nephrol; 2023 Nov; 24(1):353. PubMed ID: 38036951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically-ill patients with acute kidney injury (AKI).
    Caires RA; Abdulkader RCRM; Costa E Silva VT; Ferreira GS; Burdmann EA; Yu L; Macedo E
    J Nephrol; 2016 Jun; 29(3):401-409. PubMed ID: 26298845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis.
    Lenga I; Hopman WM; O'Connell AJ; Hume F; Wei CCY
    BMC Nephrol; 2019 Dec; 20(1):452. PubMed ID: 31805883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained low-efficiency dialysis with regional citrate anticoagulation is a suitable therapeutic option for refractory hypermagnesemia in critically ill patients with AKI.
    Menegazzo B; Regolisti G; Greco P; Maccari C; Lieti G; Delsante M; Fiaccadori E; Di Mario F
    J Nephrol; 2024 May; 37(4):1171-1174. PubMed ID: 38319546
    [No Abstract]   [Full Text] [Related]  

  • 32. Feasibility and efficacy of modified fixed citrate concentration protocol using only commercial preparations in critically ill patients: a prospective cohort study with a historical control group.
    Shi Y; Qin HY; Peng JM; Hu XY; Du B
    BMC Anesthesiol; 2021 Mar; 21(1):96. PubMed ID: 33784963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.
    Schneider M; Liefeldt L; Slowinski T; Peters H; Neumayer HH; Morgera S
    Int J Artif Organs; 2008 Jan; 31(1):43-8. PubMed ID: 18286453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrate anticoagulation in the ICU: the Leeds experience.
    Trumper C
    Br J Nurs; 2016 Sep; 25(16):902-6. PubMed ID: 27615524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.
    Yu Y; Bai M; Wei Z; Zhao L; Li Y; Ma F; Sun S
    Ren Fail; 2020 Nov; 42(1):748-758. PubMed ID: 32718221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R; Niles JL
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF
    Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R; Laliberte KA; Niles JL
    Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies.
    Lin T; Song L; Huang R; Huang Y; Tang S; Lin Q; Zhang Y; Wu X; Liang H; Wu Y; Chen Y; Liang H; Ma J; Feng Z; Li Z; Xu L; Fu X; Ye Z; Liu S; Liang X
    BMC Nephrol; 2019 Dec; 20(1):472. PubMed ID: 31856749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding.
    Betjes MG; van Oosterom D; van Agteren M; van de Wetering J
    J Nephrol; 2007; 20(5):602-8. PubMed ID: 17918147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.